Caspian Oliai

Title(s)	HS Assistant Clinical Professor, Medicine
School	Medicine
vCard	Download vCard

ORNG Applications

Clinical Trials

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia. Leuk Lymphoma. 2024 Jan; 65(1):69-77. Gaut D, Oliai C, Boiarsky J, Zhang S, Salhotra A, Azenkot T, Kennedy VE, Khanna V, Olmedo Gutierrez K, Shukla N, Moskoff B, Park G, Afkhami M, Patel A, Jeyakumar D, Mannis G, Logan AC, Jonas BA, Schiller G. PMID: 37801340.

View in: PubMed Mentions: Fields:
Hem Hematology Neo Neoplasms
Translation:Humans
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions. Blood Adv. 2023 08 22; 7(16):4528-4538. Major A, Yu J, Shukla N, Che Y, Karrison TG, Treitman R, Kamdar MK, Haverkos BM, Godfrey J, Babcook MA, Voorhees TJ, Carlson S, Gaut D, Oliai C, Romancik JT, Winter AM, Hill BT, Bansal R, Villasboas Bisneto JC, Nizamuddin IA, Karmali R, Fitzgerald LA, Stephens DM, Pophali PA, Trabolsi A, Schatz JH, Hu M, Bachanova V, Slade MJ, Singh N, Ahmed N, McGuirk JP, Bishop MR, Riedell PA, Kline J. PMID: 37026796; PMCID: PMC10425681.

View in: PubMed Mentions: 4 Fields:
Hem Hematology
Translation:Humans
Transient SARS-CoV-2 RNA-Dependent RNA Polymerase Mutations after Remdesivir Treatment for Chronic COVID-19 in Two Transplant Recipients: Case Report and Intra-Host Viral Genomic Investigation. Microorganisms. 2023 Aug 16; 11(8). Yang S, Multani A, Garrigues JM, Oh MS, Hemarajata P, Burleson T, Green NM, Oliai C, Gaynor PT, Beaird OE, Winston DJ, Seet CS, Schaenman JM. PMID: 37630656; PMCID: PMC10460003.

View in: PubMed Mentions: 2
Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin Lymphoma. Transplant Cell Ther. 2023 07; 29(7):449.e1-449.e7. Ahmed N, Wesson W, Mushtaq MU, Porter DL, Nasta SD, Brower J, Bachanova V, Hu M, Nastoupil LJ, Oluwole OO, Patel VG, Oliai C, Riedell PA, Bishop MR, Shah GL, Perales MA, Schachter L, Maziarz RT, McGuirk JP. PMID: 37120134.

View in: PubMed Mentions: 1 Fields:
Hem Hematology Tra Transplantation
Translation:Humans
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma. Cancer Discov. 2023 03 01; 13(3):580-597. Larson SM, Walthers CM, Ji B, Ghafouri SN, Naparstek J, Trent J, Chen JM, Roshandell M, Harris C, Khericha M, Schweppe T, Berent-Maoz B, Gosliner SB, Almaktari A, Ceja MA, Allen-Auerbach MS, Said J, Nawaly K, Mead M, de Vos S, Young PA, Oliai C, Schiller GJ, Timmerman JM, Ribas A, Chen YY. PMID: 36416874; PMCID: PMC9992104.

View in: PubMed Mentions: 9 Fields:
Neo Neoplasms
Translation:Humans Cells
NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022. J Natl Compr Canc Netw. 2023 02; 21(2):108-115. Saad A, Loren A, Bolaños-Meade J, Chen G, Couriel D, Di Stasi A, El-Jawahri A, Elmariah H, Farag S, Gundabolu K, Gutman J, Ho V, Hoeg R, Horwitz M, Hsu J, Kassim A, Kharfan Dabaja M, Magenau J, Martin T, Mielcarek M, Moreira J, Nakamura R, Nieto Y, Ninos C, Oliai C, Patel S, Randolph B, Schroeder M, Tzachanis D, Varshavsky-Yanovsky AN, Vusirikala M, Algieri F, Pluchino LA. PMID: 36791762.

View in: PubMed Mentions: Fields:
Neo Neoplasms
Translation:Humans
Outcomes of allogeneic hematopoietic stem cell transplantation in secondary central nervous system lymphoma: a case series. Leuk Lymphoma. 2023 02; 64(2):507-510. Gaut D, Oliai C, Mead M. PMID: 36647839.

View in: PubMed Mentions: Fields:
Hem Hematology Neo Neoplasms
Translation:Humans
R-CHOP Vs DA-EPOCH-R for Double-Expressor Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective Analysis. Clin Lymphoma Myeloma Leuk. 2022 10; 22(10):e947-e957. Othman T, Penaloza J, Zhang S, Daniel CE, Gaut D, Oliai C, Brem EA, Baweja A, Ly J, Reid J, Pinter-Brown L, Lee M, Abdulhaq H, Tuscano J. PMID: 35858904.

View in: PubMed Mentions: 1 Fields:
Neo Neoplasms
Translation:Humans
Diminished durability of chimeric antigen receptor T-cell efficacy with severe or prolonged postinfusion cytopenias. Am J Hematol. 2022 07; 97(7):E249-E255. Tabbara N, Sharp J, Gaut D, Pham TTD, Tang K, Oliai C, Sim MS, Schiller G, Young P, Sasine JP. PMID: 35358346.

View in: PubMed Mentions: 2 Fields:
Hem Hematology
Translation:Humans Cells
Outcomes of allogeneic transplantation after hypomethylating agents with venetoclax in acute myeloid leukemia. Am J Hematol. 2022 06 01; 97(6):E191-E194. Kennedy VE, Hui G, Azenkot T, Gaut D, Wieduwilt MJ, Oliai C, Jonas BA, Mittal V, Logan AC, Muffly LS, Mannis GN. PMID: 35266185.

View in: PubMed Mentions: 4 Fields:
Hem Hematology
Translation:Humans
Anti-CD19 CAR T-cell therapy remission despite prior anti-CD19 antibody Tafasitamab in relapsed/refractory DLBCL. Leuk Res Rep. 2021; 16:100260. Tabbara N, Gaut D, Oliai C, Lewis T, de Vos S. PMID: 34354920; PMCID: PMC8322434.

View in: PubMed Mentions: 4
How to address second and therapy-related acute myelogenous leukaemia. Br J Haematol. 2020 01; 188(1):116-128. Oliai C, Schiller G. PMID: 31863469.

View in: PubMed Mentions: 14 Fields:
Hem Hematology
Translation:Humans
Clinical features of pseudocirrhosis in metastatic breast cancer. Breast Cancer Res Treat. 2019 Sep; 177(2):409-417. Oliai C, Douek ML, Rhoane C, Bhutada A, Ge PS, Runyon BA, Wang X, Hurvitz SA. PMID: 31175499; PMCID: PMC6664810.

View in: PubMed Mentions: 14 Fields:
Neo Neoplasms
Translation:Humans
Liposomal Cytarabine-Daunorubicin (CPX-351) Extravasation: Case Report and Literature Review. Anticancer Res. 2018 Dec; 38(12):6927-6930. Howell G, Oliai C, Schiller G. PMID: 30504411.

View in: PubMed Mentions: 1 Fields:
Neo Neoplasms
Translation:Humans
Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients With Acute Myeloid Leukemia. Curr Treat Options Oncol. 2018 10 25; 19(12):63. Levin-Epstein R, Oliai C, Schiller G. PMID: 30362051.

View in: PubMed Mentions: 10 Fields:
Neo Neoplasms
Translation:Humans Cells
Propensity score matched comparison of SBRT versus IMRT for the treatment of localized prostate cancer. J Radiat Oncol. 2016; 5:187-195. Oliai C, Bernetich M, Brady L, Yang J, Hanlon A, Lamond J, Arrigo S, Good M, Mooreville M, Garber B, Lanciano R. PMID: 27335630; PMCID: PMC4893387.

View in: PubMed Mentions: 5
Breast cancer: The debate over post-mastectomy radiotherapy should continue. Nat Rev Clin Oncol. 2015 Oct; 12(10):567-8. Oliai C, Hurvitz SA. PMID: 26323387.

View in: PubMed Mentions: 1 Fields:
Neo Neoplasms
Translation:Humans
SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate Risk on Outcome Utilizing 2.2014 NCCN Risk Stratification Guidelines. Front Oncol. 2014; 4:312. Bernetich M, Oliai C, Lanciano R, Hanlon A, Lamond J, Arrigo S, Yang J, Good M, Feng J, Brown R, Garber B, Mooreville M, Brady LW. PMID: 25426447; PMCID: PMC4227393.

View in: PubMed Mentions: 17
Radioprotectants to reduce the risk of radiation-induced carcinogenesis. Int J Radiat Biol. 2014 Mar; 90(3):203-13. Oliai C, Yang LX. PMID: 24164532.

View in: PubMed Mentions: 5 Fields:
Rad Radiology
Translation:Humans Animals
Clinical experience using accelerated partial breast irradiation for ductal carcinoma in situ. Breast J. 2013 Mar-Apr; 19(2):217-9. Fisher B, Oliai C, Wong M, Soni P, Shaikh T, Komarnicky LT. PMID: 23458220.

View in: PubMed Mentions: Fields:
Neo Neoplasms
Translation:Humans
Stereotactic body radiation therapy for the primary treatment of localized prostate cancer. J Radiat Oncol. 2013 Mar; 2(1):63-70. Oliai C, Lanciano R, Sprandio B, Yang J, Lamond J, Arrigo S, Good M, Mooreville M, Garber B, Brady LW. PMID: 23504305; PMCID: PMC3594824.

View in: PubMed Mentions: 27
Hyperbaric oxygen therapy for radiation-induced cystitis and proctitis. Int J Radiat Oncol Biol Phys. 2012 Nov 01; 84(3):733-40. Oliai C, Fisher B, Jani A, Wong M, Poli J, Brady LW, Komarnicky LT. PMID: 22440041.

View in: PubMed Mentions: 28 Fields:
Neo Neoplasms Rad Radiology Rad Radiotherapy
Translation:Humans PHPublic Health
Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo. J Immunol. 2011 Apr 15; 186(8):4599-608. Dolfi DV, Duttagupta PA, Boesteanu AC, Mueller YM, Oliai CH, Borowski AB, Katsikis PD. PMID: 21389258.

View in: PubMed Mentions: 40 Fields:
All Allergy and Immunology
Translation:Animals Cells